Opinion: Managing a pharma company during three crises: lessons learned for Covid-19
When I started working in the biopharma industry 20 or so years ago, I didn’t think I would need to become an expert in crisis management. Yet during the past decade, I have found myself leading the corporate response to three very different existential crises in three different regions.
Despite the unique aspects of each situation, they share important commonalities that shed some light on actions and attitudes that can help guide and improve corporate leaders’ response to the coronavirus pandemic, in the United States and globally.
